Search

PharmaAthene gets $5.8M Add-on from DoD for Protexia

The Defense Department is awarding another $5.8 million to PharmAthene [PIP] for continued development of Protexia, the company's broad spectrum nerve agent prophylaxis. PharmaAthene in Sept. 2006 received a potential $213 million contract from the Army Space and Missile Command for advanced development of Protexia. As a prophylactic Protexia may reduce or eliminate the need for post-exposure therapeutics.

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.



Congress Updates

Build Of At Least 45 MQ-9s By Start Of FY 2029 Required By SASC Bill

Down to an inventory of 135 MQ-9A Reapers due to the loss of two dozen aircraft in strikes on Iran, the Air Force would have to field at least 45 […]


Kaine On Iranian Girls School Strike: “You Can Be Sure We’re Gonna Get The Answer To That One”

Sen. Timothy Kaine (D-Va.), the ranking member of the Senate Armed Services Committee (SASC) seapower panel, pledged on Tuesday that the Senate will get to the bottom of what happened […]


‘Right To Repair’ Reform In SASC’s FY ‘27 NDAA Sets “Government-Purpose Rights’ As Default

The “Right to Repair” provision secured in the Senate Armed Services Committee’s (SASC) version of the next defense policy bill would establish “government-purpose rights”  as a default, requiring defense contractors […]


Pentagon May Make ‘Tradeoffs’ For Low-Cost Autonomous Tech Without Reconciliation Funds, CTO Says

The Pentagon’s chief technology officer has said the department may need to make “tradeoffs” on certain capability priorities if Congress doesn’t pass a reconciliation with $350 billion in requested defense […]